Li Yansen, Li Ming, Li Chang, Chang Jing, Hui Yuwen, Wang Chuanlin, Guo Wei, Li Zhulin
Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, 100069, China.
Trauma Medicine Center, Peking University People's Hospital, Beijing, 100044, China.
Heliyon. 2024 Mar 15;10(6):e28047. doi: 10.1016/j.heliyon.2024.e28047. eCollection 2024 Mar 30.
In trauma first aid, rapid hemostasis is a priority, extricating patients from hemorrhagic shock and infection risks. This paper explores novel hemostatic materials, using ion-crosslinking and freeze-drying techniques. Iterative experiments determined optimal conditions for the temperature-variable mixing-freeze-drying chemical reaction of sodium alginate (SA)/silk fibroin (SF). We used SA, SA/SF, SA/SF-TB and commercial hemostatic sponge control samples to perform hemostasis experiments on rat liver injury and femoral artery injury models, and to perform wound healing experiments on rat back full-layer skin. The results showed that the hemostatic time and blood loss of SA/SF-TB group rats (liver hemorrhage model: 397.17 ± 34.80 mg, 77.83 ± 7.41 s; Femoral artery bleeding model: 940.33 ± 41.93 mg, 96.83 ± 4.07 s) was significantly better than other experimental groups, and similar to the commercial group. The wound healing experiment showed that the new granulation tissue thickness of SA/SF-TB group was thicker (380.39 ± 28.56 μm) at day 14. In addition, the material properties and biocompatibility of sponges were characterized by cell experiments and in vivo embedding experiments. All the results showed that the SA/SF-TB hemostatic sponge prepared in this study could not only seal the wound quickly and stop bleeding, but also promote the growth of epidermal cells and fibroblasts and accelerate wound healing. This new material solves the shortcomings of traditional materials such as low stability, limited shelf life, high unit price, and has good biocompatibility, easy preparation, rapid hemostasis and other excellent properties. Therefore, this innovative hemostatic material has great prospects and potential in clinical applications.
在创伤急救中,快速止血是首要任务,可使患者摆脱失血性休克和感染风险。本文利用离子交联和冷冻干燥技术探索新型止血材料。通过反复实验确定了海藻酸钠(SA)/丝素蛋白(SF)变温混合冷冻干燥化学反应的最佳条件。我们使用SA、SA/SF、SA/SF-TB以及商用止血海绵对照样品,在大鼠肝损伤和股动脉损伤模型上进行止血实验,并在大鼠背部全层皮肤进行伤口愈合实验。结果显示,SA/SF-TB组大鼠的止血时间和失血量(肝出血模型:397.17±34.80mg,77.83±7.41秒;股动脉出血模型:940.33±41.93mg,96.83±4.07秒)明显优于其他实验组,且与商用组相近。伤口愈合实验表明,在第14天时SA/SF-TB组的新生肉芽组织厚度更厚(380.39±28.56μm)。此外,通过细胞实验和体内植入实验对海绵的材料特性和生物相容性进行了表征。所有结果表明,本研究制备的SA/SF-TB止血海绵不仅能快速封闭伤口、止血,还能促进表皮细胞和成纤维细胞生长,加速伤口愈合。这种新材料解决了传统材料稳定性低、保质期有限、单价高的缺点,具有良好的生物相容性、易于制备、快速止血等优异性能。因此,这种创新型止血材料在临床应用中具有广阔前景和潜力。